THE RET ONCOGENE PRODUCTS ARE MEMBRANE-BOUND GLYCOPROTEINS PHOSPHORYLATED ON TYROSINE RESIDUES INVIVO

被引:19
作者
TANIGUCHI, M
IWAMOTO, T
HAMAGUCHI, M
MATSUYAMA, M
TAKAHASHI, M
机构
[1] NAGOYA UNIV,SCH MED,DEPT PATHOL,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
[2] NAGOYA UNIV,SCH MED,DEPT IMMUNOL,SHOWA KU,NAGOYA,AICHI 466,JAPAN
[3] NAGOYA UNIV,SCH MED,DIS MECH & CONTROL RES INST,SHOWA KU,NAGOYA,AICHI 466,JAPAN
关键词
D O I
10.1016/S0006-291X(05)81435-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We identified ret oncogene products in NIH 3T3 cells transformed by the ret oncogene (NIH(ret)) and a cell line (Lym-ret) established from pre-B cell lymphoma which developed in Eμ-ret transgenic mice. Using the polyclonal antibody against the kinase domain of ret, two glycoproteins with apparent molecular weights of 100kd and 96kd were found in both cell lines, although the expression level of the 100kd protein was much higher than that of the 96kd protein. Cell fractionation experiments indicated that the 100kd protein was present predominantly in the membrane fraction while the 96kd protein was found in both membrane and cytosol fractions. Western blot analysis indicated that the 100kd ret protein was phosphorylated on tyrosine residues in vivo. © 1991 Academic Press, Inc.
引用
收藏
页码:416 / 422
页数:7
相关论文
共 19 条
[1]  
DONGHI R, 1989, ONCOGENE, V4, P521
[2]   CDNA CLONING OF A NOVEL 85KD PROTEIN THAT HAS SH2 DOMAINS AND REGULATES BINDING OF PI3-KINASE TO THE PDGF BETA-RECEPTOR [J].
ESCOBEDO, JA ;
NAVANKASATTUSAS, S ;
KAVANAUGH, WM ;
MILFAY, D ;
FRIED, VA ;
WILLIAMS, LT .
CELL, 1991, 65 (01) :75-82
[3]   PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS [J].
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
MELILLO, RM ;
DONGHI, R ;
BONGARZONE, I ;
PIEROTTI, MA ;
DELLAPORTA, G ;
FUSCO, A ;
VECCHIO, G .
CELL, 1990, 60 (04) :557-563
[4]   PHOSPHORYLATION OF CELLULAR PROTEINS IN ROUS-SARCOMA VIRUS-INFECTED CELLS - ANALYSIS BY USE OF ANTI-PHOSPHOTYROSINE ANTIBODIES [J].
HAMAGUCHI, M ;
GRANDORI, C ;
HANAFUSA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (08) :3035-3042
[5]  
ISHIZAKA Y, 1989, ONCOGENE, V4, P789
[6]  
ISHIZAKA Y, 1989, ONCOGENE, V4, P1519
[7]   CDNA CLONING AND CHARACTERIZATION OF RET ACTIVATED IN A HUMAN PAPILLARY THYROID-CARCINOMA CELL-LINE [J].
ISHIZAKA, Y ;
USHIJIMA, T ;
SUGIMURA, T ;
NAGAO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (02) :402-408
[8]   PREFERENTIAL DEVELOPMENT OF PRE-B-LYMPHOMAS WITH DRASTICALLY DOWN-REGULATED N-MYC IN THE E-MU-RET TRANSGENIC MICE [J].
IWAMOTO, T ;
PU, MY ;
ITO, M ;
TAKAHASHI, M ;
ISOBE, K ;
NAGASE, F ;
KAWASHIMA, K ;
ICHIHARA, M ;
NAKASHIMA, I .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (08) :1809-1814
[9]  
KODA T, 1988, Hokkaido Journal of Medical Science, V63, P913
[10]   MOLECULAR AND BIOCHEMICAL-CHARACTERIZATION OF THE HUMAN TRK PROTO-ONCOGENE [J].
MARTINZANCA, D ;
OSKAM, R ;
MITRA, G ;
COPELAND, T ;
BARBACID, M .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (01) :24-33